Product ID |
Product Name |
CAS# |
Purity |
Y1249523 |
Nicodicosapent |
1269181-69-2 |
98% |
Y1258222 |
Beclabuvir |
958002-33-0 |
99% |
Y1258135 |
BAY-678 racemate |
675103-35-2 |
97% |
Y1258223 |
NSC232003 |
1905453-18-0 |
98% |
Y1289911 |
AZD7986 |
1802148-05-5 |
98% |
Y1249066 |
Veledimex S enantiomer |
1093131-03-3 |
99% |
Y1253546 |
Veledimex |
1093130-72-3 |
99% |
Y1253547 |
Tiglyl carnitine |
64681-36-3 |
95% |
D775149 |
Stearoylcarnitine |
25597-09-5 |
97.0% |
Y1253449 |
Leu-AMS |
288591-93-5 |
97% |
Y1257762 |
Aminoacyl tRNA synthetase-IN-1 |
219931-45-0 |
99% |
Y1253496 |
PSB-12062 |
55476-47-6 |
99% |
Y1249037 |
(+)-SJ733 |
1424799-20-1 |
99% |
Y1253509 |
PF-06471553 |
1808094-07-6 |
98% |
Y1257786 |
MGAT2-IN-1 |
1800025-30-2 |
99% |
Y3287293 |
RWJ 63556 |
190967-35-2 |
99% |
Y3311924 |
SM-6586 |
103898-38-0 |
99% |
Y1249068 |
Pico145 |
1628287-16-0 |
98% |
Y1249038 |
ML204 hydrochloride |
2070015-10-8 |
98% |
Y1257763 |
Tenatoprazole sodium |
335299-59-7 |
98% |
Y1257788 |
Naminidil |
220641-11-2 |
99% |
Y3305127 |
Phe-Met-Arg-Phe amide trifluoroacetate |
159237-99-7 |
99.90% |
Y1257750 |
(R)-BPO-27 |
1415390-47-4 |
99% |
Y1257770 |
BCRP-IN-1 |
1699720-85-8 |
98% |
Y3104229 |
FMK-MEA |
1414811-15-6 |
99% |
Y1257771 |
SLV-2436 |
2095704-43-9 |
97% |
Y3306990 |
Calcium channel-modulator-1 |
136941-70-3 |
99% |
Y3304925 |
McN5691 |
99254-95-2 |
97% |
Y1257751 |
SK1-IN-1 |
1218816-71-7 |
98% |
Y1253377 |
PD-1-IN-1 |
1673534-76-3 |
99% |
Y1249371 |
TLR7-agonist-1 |
1642857-69-9 |
99% |
Y1249415 |
Neoseptin 3 |
1622863-21-1 |
98% |
Y1245116 |
CU-CPT17e |
2109805-75-4 |
98% |
Y1240541 |
WAY-151932 |
220460-92-4 |
99% |
Y1249372 |
Org41841 |
301847-37-0 |
99% |
Y1245074 |
MK-4256 |
1104599-69-0 |
99% |
Y1249417 |
NFAT Transcription Factor Regulator |
245747-71-1 |
98% |
Y1249379 |
GIBH-130 |
1252608-59-5 |
98% |
Y3309366 |
H3 receptor-MO-1 |
1240914-03-7 |
99% |
Y1343584 |
MK-0249 |
862309-06-6 |
99% |
Y1266997 |
FR-188582 |
189699-82-9 |
99% |
Y3309315 |
COX2-IN-1 |
134729-13-8 |
98% |
Y1266941 |
SC57666 |
158959-32-1 |
98% |
Y1266844 |
GSK2239633A |
1240516-71-5 |
99% |
Y3105118 |
CCR1 antagonist 1 |
1010073-75-2 |
99% |
Y3305182 |
Bamirastine |
215529-47-8 |
96% |
Y3304701 |
Rocastine |
91833-49-7 |
98% |
Y3307476 |
Wy 49051 |
113418-56-7 |
97% |
Y1266845 |
PF-3893787 hydrochloride |
2096455-90-0 |
98% |
Y1266944 |
Pan-RAS-IN-1 |
1835283-94-7 |
99% |
Y1334960 |
1A-116 |
1430208-73-3 |
98% |
Y1341013 |
AZD1979 |
1254035-84-1 |
95% |
Y3311734 |
CGS 15435 |
95853-92-2 |
99% |
Y3311453 |
EP1-antanoist-1 |
851204-35-8 |
98% |
Y3295041 |
KP496 |
217799-03-6 |
99% |
Y1262621 |
(R)-ADX-47273 |
851881-59-9 |
99% |
Y1343298 |
PBI-4050 sodium salt |
1254472-97-3 |
99% |
Y1262646 |
INT-777 R-enantiomer |
1198786-98-9 |
98% |
Y3306007 |
opigolix |
912587-25-8 |
98% |
Y3305545 |
AZP-531 |
1088543-62-7 |
98.54% |
Y3315532 |
HAEGTFTSD |
926018-45-3 |
98% |
Y3312685 |
HAEGTFTSDVS |
864915-61-7 |
98.31% |
Y3318288 |
HAEGTFT |
926018-95-3 |
99% |
Y1236227 |
GLP-1 receptor agonist-1 |
2230197-64-3 |
99% |
Y1262649 |
Litronesib Racemate |
546111-97-1 |
99% |
Y1266857 |
Taranabant ((1R,2R)stereoisomer) |
701977-08-4 |
98% |
Y3318638 |
L162389 |
169281-53-2 |
99% |
Y3308491 |
a1 adrenoceptor-MO-1 |
161905-64-2 |
98% |
Y3306688 |
TD-5471 hydrochloride |
530084-35-6 |
99% |
Y3305435 |
OPC-28326 |
167626-17-7 |
98% |
Y3304738 |
A2B receptor antagonist 1 |
531506-36-2 |
98% |
Y1266975 |
OSIP-486823 |
200803-37-8 |
98% |
Y3305729 |
Adenosine antagonist-1 |
431040-19-6 |
99% |
Y1236322 |
N-[(4-Aminophenyl)methyl]adenosine |
95523-13-0 |
98% |
Y1236232 |
PSB-12379 |
1802226-78-3 |
99% |
Y1344139 |
AGN 192836 |
171102-29-7 |
98% |
Y1236246 |
Banoxantrone D12 dihydrochloride |
1562066-98-1 |
98% |
Y3311647 |
Banoxantrone D12 |
1562067-05-3 |
98% |
Y1262625 |
GSK376501A |
1010412-80-2 |
99% |
Y1262535 |
PPAR agonist 1 |
539813-69-9 |
96% |
Y1236233 |
Phen-DC3 Trifluoromethanesulfonate |
929895-45-4 |
99% |
Y3288115 |
GDC-0575 dihydrochloride |
1657014-42-0 |
99% |
Y3309771 |
CHK-IN-1 |
1278405-51-8 |
100% |
Y1241205 |
MRT68921 hydrochloride |
2080306-21-2 |
99% |
Y1344295 |
NU6300 |
2070015-09-5 |
96% |
Y1241210 |
Trilaciclib hydrochloride |
1977495-97-8 |
99% |
Y1340102 |
CT7001 hydrochloride |
1805789-54-1 |
99% |
Y1249524 |
GNE-7915 tosylate |
2070015-00-6 |
99% |
Y1253911 |
Biotin-VAD-FMK |
1135688-15-1 |
98% |
Y1249444 |
XRK3F2 |
2375193-43-2 |
98% |
Y1258137 |
SMER18 |
944153-47-3 |
98% |
Y1249526 |
SR9011 hydrochloride |
2070014-94-5 |
98% |
Y3288972 |
S55746 hydrochloride |
1448525-91-4 |
99% |
Y1258138 |
Lys01 trihydrochloride |
1391426-24-6 |
98% |
Y3252910 |
sulfo-SPDB-DM4 |
1626359-59-8 |
99% |
Y1258204 |
Deruxtecan analog |
1599440-13-7 |
98% |
Y1245129 |
DC1-SMe |
501666-85-9 |
98% |
Y1253808 |
RSV-IN-1 |
861139-16-4 |
99% |
Y1290043 |
Baloxavir |
1985605-59-1 |
98% |
Y1258224 |
RIG-1 modulator 1 |
1428729-63-8 |
99% |